Reaction

T-Cell Type Acute Leukaemia reporting signals

Last recalculated 2026-09-14T18:28:35.993900+00:00 · 203 reports · 4 co-occurring drugs

As of the last recalculation, T-Cell Type Acute Leukaemia appears in 203 FAERS reports alongside 4 co-occurring drug terms. The strongest observed disproportionality signal is MERCAPTOPURINE (PRR 75.3).

Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.
DrugCo-reportsPRRROR
Mercaptopurine1275.375.4
Etoposide3762.962.9
Cytarabine3059.959.9
Azacitidine For846.946.9

Related reactions

Data source: openFDA FAERS. See the OpenPV methodology and limitations.